Press Releases

Date	Title	Company
17-Apr-2026	Soley Therapeutics Presents Preclinical Data Demonstrating Selective Anti-Tumor Activity of STX-6398, a First-in-Class CKAP2 Modulator, at AACR 2026	Businesswire
17-Apr-2026	Medicure Announces Resignation of President and Chief Operating Officer	ACCESS Newswire
17-Apr-2026	Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development	ACCESS Newswire
17-Apr-2026	Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	Businesswire
17-Apr-2026	Cantargia Announces AACR 2026 Presentation of Study Design and Supportive Pre-Clinical Data for Investigator-Initiated Nadunolimab Study in MSS CRC	ACCESS Newswire
17-Apr-2026	Mountain Valley MD Announces Appointment of Advisors and Stock Option Grants	Businesswire
17-Apr-2026	Volastra Therapeutics Announces Biomarker and Combination Data around AACR 2026 Defining an Rb Pathway-Driven Pan-Cancer Development Strategy for KIF18A Inhibitors	Businesswire
17-Apr-2026	Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026 AACR Annual Meeting	ACCESS Newswire
17-Apr-2026	European Commission Approves Merck’s ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants During Their First RSV Season	Businesswire
17-Apr-2026	Drug Farm to Present Positive Phase 1b Data for First-in-Class ALPK1 Inhibitor DF-003 in ROSAH Syndrome at IMMUNOLOGY2026™	Businesswire
17-Apr-2026	Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health	ACCESS Newswire
17-Apr-2026	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
17-Apr-2026	Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026	Businesswire
17-Apr-2026	Notice of Annual General Meeting in Senzime AB (publ)	ACCESS Newswire
17-Apr-2026	Licensed Agents and Insurance Agencies Can Now Run Their Entire Practice from a Single AI-Powered Insurance Platform at No Upfront Cost	ACCESS Newswire
17-Apr-2026	Electronic Skin Market: The Future of Smart, Responsive Technology	Market Business Insights
17-Apr-2026	Innovative Trials appoints first Chief Operating Officer to strengthen patient-centered services and accelerate global growth	Innovative Trials
17-Apr-2026	Conference Call on Interim Report January-March 2026	ACCESS Newswire
17-Apr-2026	Aspire Biopharma's Buzz Bomb(TM) Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon Expo	ACCESS Newswire
17-Apr-2026	Lifeasible Expands Rice Transformation Platform Using Agrobacterium-Mediated Technology	Lifeasible